<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=ADMB-3TMS-PRINACA</id>
	<title>ADMB-3TMS-PRINACA - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=ADMB-3TMS-PRINACA"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=ADMB-3TMS-PRINACA&amp;action=history"/>
	<updated>2026-04-07T04:32:23Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=ADMB-3TMS-PRINACA&amp;diff=6427832&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=ADMB-3TMS-PRINACA&amp;diff=6427832&amp;oldid=prev"/>
		<updated>2025-03-05T06:14:49Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== ADMB-3TMS-PRINACA ==&lt;br /&gt;
&lt;br /&gt;
[[File:ADMB-3TMS-PRINACA_structure.png|Chemical structure of ADMB-3TMS-PRINACA|thumb|right]]&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;ADMB-3TMS-PRINACA&amp;#039;&amp;#039;&amp;#039; is a synthetic cannabinoid that has been identified in various designer drug products. It is part of the indazole-3-carboxamide family, which is known for its potent activity at the [[cannabinoid receptor]]s. These compounds are often used recreationally for their psychoactive effects, mimicking those of [[tetrahydrocannabinol]] (THC), the active component in [[cannabis]].&lt;br /&gt;
&lt;br /&gt;
== Chemical Structure and Properties ==&lt;br /&gt;
&lt;br /&gt;
ADMB-3TMS-PRINACA is characterized by its indazole core structure, which is substituted at the 1-position with a 3,3-dimethylbutanoyl group and at the 3-position with a 3-(trimethylsilyl)propyl group. This specific configuration contributes to its high affinity for the cannabinoid receptors, particularly [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]].&lt;br /&gt;
&lt;br /&gt;
The chemical formula of ADMB-3TMS-PRINACA is C23H36N2O2Si, and it has a molecular weight of 400.63 g/mol. The presence of the trimethylsilyl group is notable, as it is a common feature in synthetic cannabinoids designed to evade legal restrictions by altering the chemical structure slightly while maintaining psychoactive properties.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
&lt;br /&gt;
ADMB-3TMS-PRINACA acts as a potent agonist at the cannabinoid receptors. These receptors are part of the [[endocannabinoid system]], which plays a role in regulating various physiological processes including mood, memory, appetite, and pain sensation. The activation of these receptors by synthetic cannabinoids can lead to effects similar to those of THC, such as euphoria, relaxation, and altered perception.&lt;br /&gt;
&lt;br /&gt;
However, synthetic cannabinoids like ADMB-3TMS-PRINACA can also produce severe adverse effects, including [[tachycardia]], [[hypertension]], [[hallucinations]], and [[psychosis]]. The potency and unpredictable nature of these compounds pose significant health risks to users.&lt;br /&gt;
&lt;br /&gt;
== Legal Status ==&lt;br /&gt;
&lt;br /&gt;
Due to their potential for abuse and harmful effects, many synthetic cannabinoids, including ADMB-3TMS-PRINACA, have been classified as controlled substances in various jurisdictions. Regulatory agencies continue to monitor and update the legal status of these compounds as new variants are developed and identified.&lt;br /&gt;
&lt;br /&gt;
== Related Pages ==&lt;br /&gt;
&lt;br /&gt;
* [[Synthetic cannabinoids]]&lt;br /&gt;
* [[Cannabinoid receptor]]&lt;br /&gt;
* [[Endocannabinoid system]]&lt;br /&gt;
* [[Designer drugs]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Synthetic cannabinoids]]&lt;br /&gt;
[[Category:Designer drugs]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>